Cargando…
Procalcitonin: “To Follow or Not to Follow” That's the Question
How to cite this article: Todi SK. Procalcitonin: “To Follow or Not to Follow” That's the Question. Indian J Crit Care Med 2021;25(5):484–485.
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Jaypee Brothers Medical Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196389/ https://www.ncbi.nlm.nih.gov/pubmed/34177162 http://dx.doi.org/10.5005/jp-journals-10071-23840 |
_version_ | 1783706678737240064 |
---|---|
author | Todi, Subhash K |
author_facet | Todi, Subhash K |
author_sort | Todi, Subhash K |
collection | PubMed |
description | How to cite this article: Todi SK. Procalcitonin: “To Follow or Not to Follow” That's the Question. Indian J Crit Care Med 2021;25(5):484–485. |
format | Online Article Text |
id | pubmed-8196389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Jaypee Brothers Medical Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-81963892021-06-24 Procalcitonin: “To Follow or Not to Follow” That's the Question Todi, Subhash K Indian J Crit Care Med Editorial How to cite this article: Todi SK. Procalcitonin: “To Follow or Not to Follow” That's the Question. Indian J Crit Care Med 2021;25(5):484–485. Jaypee Brothers Medical Publishers 2021-05 /pmc/articles/PMC8196389/ /pubmed/34177162 http://dx.doi.org/10.5005/jp-journals-10071-23840 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© Jaypee Brothers Medical Publishers. 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Editorial Todi, Subhash K Procalcitonin: “To Follow or Not to Follow” That's the Question |
title | Procalcitonin: “To Follow or Not to Follow” That's the Question |
title_full | Procalcitonin: “To Follow or Not to Follow” That's the Question |
title_fullStr | Procalcitonin: “To Follow or Not to Follow” That's the Question |
title_full_unstemmed | Procalcitonin: “To Follow or Not to Follow” That's the Question |
title_short | Procalcitonin: “To Follow or Not to Follow” That's the Question |
title_sort | procalcitonin: “to follow or not to follow” that's the question |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196389/ https://www.ncbi.nlm.nih.gov/pubmed/34177162 http://dx.doi.org/10.5005/jp-journals-10071-23840 |
work_keys_str_mv | AT todisubhashk procalcitonintofollowornottofollowthatsthequestion |